This Week at FDA: Kennedy faces Senate scrutiny, Trump’s ‘buyout’ offer to federal employees

This Week at FDAThis Week at FDADiagnostics/IVDsGovernment/legislationGuidanceLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)